Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.09−0.03 (-0.96%)
Close on Nov 13, 2026Market cap $769.99MP/E –Yield –
Ardelyx total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Ardelyx's total debt was $26.54M at Sep 30, 2022. For fiscal 2021 it was $32.26M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $32.26M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2022 | Sep 30, 2022 | $26.54M | – |
| Q2 FY2022 | Jun 30, 2022 | $26.37M | – |
| Q1 FY2022 | Mar 31, 2022 | $26.14M | – |
| Q4 FY2021 | Dec 31, 2021 | $32.26M | – |
See a number that looks wrong?